Sanofi (SNY) discloses $534M portfolio across 10 positions in latest 13F
Rhea-AI Filing Summary
Sanofi, as an institutional investment manager, reports its quarterly equity holdings under Form 13F. The report is filed as a 13F Holdings Report, meaning all of Sanofi’s reportable U.S.-listed positions are included in this submission.
The filing lists 10 reportable positions in the Form 13F Information Table, with an aggregate reported value of $534,041,662 (rounded to the nearest dollar). No other investment managers are included, and Sanofi’s Head of Legal Corporate & Finance, Alexandra Roger, signs on behalf of the reporting manager.
Positive
- None.
Negative
- None.
Key Figures
Form 13F Information Table Entry Total: 10
Form 13F Information Table Value Total: $534,041,662
Number of Other Included Managers: 0
3 metrics
Form 13F Information Table Entry Total
10
Number of reportable holdings listed in the Form 13F Information Table
Form 13F Information Table Value Total
$534,041,662
Aggregate value of reportable holdings, rounded to the nearest dollar
Number of Other Included Managers
0
Indicates Sanofi is the sole institutional investment manager in this report
Key Terms
Form 13F, 13F Holdings Report, Institutional investment manager
3 terms
Form 13F regulatory
"Form 13F Information Table Entry Total"
A Form 13F is a quarterly filing that large investment managers must submit to disclose their holdings in publicly traded stocks and certain other securities. It acts like a peek into the portfolios of big investors, helping other market participants see what large players are buying or selling and offering clues about investment trends, crowded trades, and potential market impact.
13F Holdings Report regulatory
"13F HOLDINGS REPORT. (Check here if all holdings"
Institutional investment manager regulatory
"The institutional investment manager filing this report"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What is Sanofi (SNY) reporting in this Form 13F filing?
Sanofi is reporting its Form 13F Holdings Report, which details all of its reportable U.S.-listed equity positions for the period. The report covers 10 holdings with a total reported value of $534,041,662.
How many securities does Sanofi (SNY) list in its latest Form 13F?
Sanofi lists 10 reportable positions in its Form 13F Information Table Entry Total. These are the equity securities that meet the SEC’s 13F reporting requirements for the period and are fully included in this holdings report.
What is the total reported value of Sanofi’s (SNY) 13F portfolio?
The total reported value of Sanofi’s 13F portfolio is $534,041,662, rounded to the nearest dollar. This figure represents the aggregate value of its 10 reportable holdings as disclosed in the Form 13F Summary Page.
Is this Sanofi (SNY) Form 13F a full holdings report or a notice?
It is a 13F Holdings Report, indicated by the checked box for that report type. This means all of Sanofi’s reportable holdings for the period are included here, rather than being reported by another manager or split across reports.
Does Sanofi (SNY) report any other included managers in this Form 13F?
No. The filing states the Number of Other Included Managers is 0 and explicitly lists “NONE” for other included managers. Sanofi alone is the institutional investment manager responsible for the reported holdings.
Who signed the Sanofi (SNY) Form 13F and in what capacity?
The report is signed by Alexandra Roger, identified as Head of Legal Corporate & Finance. The signature certifies that the information is true, correct, and complete, and that she is authorized to submit the report on Sanofi’s behalf.